financetom
Business
financetom
/
Business
/
--Assured Guaranty Maintains Quarterly Dividend at $0.31 Per Share; Payable Sept. 4 to Shareholders on Aug. 21
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Assured Guaranty Maintains Quarterly Dividend at $0.31 Per Share; Payable Sept. 4 to Shareholders on Aug. 21
Aug 7, 2024 9:33 AM

12:09 PM EDT, 08/07/2024 (MT Newswires) --

Price: 76.82, Change: -0.22, Percent Change: -0.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Oct 23, 2025
Oct 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Thursday: ** The London Stock Exchange Group ( LDNXF ) said it will sell a 20% stake in its clearing unit to a group of banks in a deal that values the business at 850 million pounds ($1.14 billion), and announced plans to...
In boost to planemaker COMAC, Brunei allows China-made jets
In boost to planemaker COMAC, Brunei allows China-made jets
Oct 23, 2025
SEOUL, Oct 23 (Reuters) - Brunei has become the latest country to allow its airlines to operate Chinese-made aircraft, according to new rules published on Thursday by Brunei's aviation regulator, in a boost for Shanghai-based planemaker COMAC. Brunei is a small market, but each advance for China-made aircraft abroad is closely watched as Beijing looks for international acceptance at a...
Moderna Says Phase 3 Trial of Cytomegalovirus Vaccine Misses Primary Endpoint
Moderna Says Phase 3 Trial of Cytomegalovirus Vaccine Misses Primary Endpoint
Oct 23, 2025
05:44 AM EDT, 10/23/2025 (MT Newswires) -- Moderna ( MRNA ) said Thursday that a phase 3 trial of mRNA-1647 investigational vaccine failed to meet its primary efficacy endpoint of preventing cytomegalovirus infection in seronegative women of childbearing age between 16 to 40 years. The company said it will discontinue development of the investigational vaccine for congenital cytomegalovirus but continue...
Miluna Acquisition Prices $60 Million Initial Public Offering
Miluna Acquisition Prices $60 Million Initial Public Offering
Oct 23, 2025
05:38 AM EDT, 10/23/2025 (MT Newswires) -- Miluna Acquisition (MMTX) said late Wednesday it priced its initial public offering of 6 million units at $10 apiece. IPO underwriters have a 45-day overallotment option to acquire up to 900,000 additional units, the blank-check company said. Each unit consists of one share and a redeemable warrant. Miluna expects its units to start...
Copyright 2023-2026 - www.financetom.com All Rights Reserved